Palmitoylethanolamide in CNS health and disease

GM Raso, R Russo, A Calignano, R Meli - Pharmacological Research, 2014 - Elsevier
The existence of acylethanolamides (AEs) in the mammalian brain has been known for
decades. Among AEs, palmitoylethanolamide (PEA) is abundant in the central nervous …

[HTML][HTML] Effects of palmitoylethanolamide on neurodegenerative diseases: a review from rodents to humans

E Landolfo, D Cutuli, L Petrosini, C Caltagirone - Biomolecules, 2022 - mdpi.com
Palmitoylethanolamide (PEA) stands out among endogenous lipid mediators for its
neuroprotective, anti-inflammatory, and analgesic functions. PEA belonging to the N …

Harnessing the anti-inflammatory potential of palmitoylethanolamide

M Alhouayek, GG Muccioli - Drug Discovery Today, 2014 - Elsevier
Highlights•PEA is an anti-inflammatory and neuroprotective compound.•Pharmacological
tools are available to control PEA levels via FAAH and NAAA inhibition.•FAAH and NAAA …

Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator

SD Skaper, L Facci, P Giusti - Molecular neurobiology, 2013 - Springer
Glia are key players in a number of nervous system disorders. Besides releasing glial and
neuronal signaling molecules directed to cellular homeostasis, glia respond also to pro …

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

S Petrosino, V Di Marzo - British journal of pharmacology, 2017 - Wiley Online Library
Palmitoylethanolamide (PEA) has emerged as a potential nutraceutical, because this
compound is naturally produced in many plant and animal food sources, as well as in cells …

Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease

C Scuderi, L Steardo - … (Formerly Current Drug Targets-CNS & …, 2013 - ingentaconnect.com
The growth of knowledge about the molecular mechanisms underlying Alzheimer's disease
(AD) has highlighted the role of neuroinflammation in the pathophysiology of this disorder …

[HTML][HTML] Synaptic effects of palmitoylethanolamide in neurodegenerative disorders

M Assogna, F Di Lorenzo, A Martorana, G Koch - Biomolecules, 2022 - mdpi.com
Increasing evidence strongly supports the key role of neuroinflammation in the
pathophysiology of neurodegenerative diseases, such as Alzheimer's disease …

[HTML][HTML] Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review

S Petrosino, A Schiano Moriello - International Journal of Molecular …, 2020 - mdpi.com
Neuroinflammation is a physiological response aimed at maintaining the homodynamic
balance and providing the body with the fundamental resource of adaptation to endogenous …

N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution

SD Skaper, L Facci, M Barbierato, M Zusso… - Molecular …, 2015 - Springer
Inflammation is fundamentally a protective cellular response aimed at removing injurious
stimuli and initiating the healing process. However, when prolonged, it can override the …

Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries

E Esposito, S Cuzzocrea - CNS & Neurological Disorders-Drug …, 2013 - ingentaconnect.com
The role of palmitoylethanolamide (PEA) in the regulation of complex systems involved in
the inflammatory response, pruritus, neurogenic and neuropathic pain is well understood …